糖尿病心血管并发症药物分子靶向递送系统的研究进展
刘妍 , 秦小江 , 魏成杰 , 江雪露 , 郑志发 , 彭晓阳 , 赵良渊 , 施熠炜 , 侯晓敏
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 808 -820.
糖尿病心血管并发症药物分子靶向递送系统的研究进展
Research progress on drug molecular targeted delivery systems for cardiovascular complications of diabetes
糖尿病(diabetes mellitus,DM)是一种以慢性高血糖为主要特征的代谢性疾病,其病理特征表现为碳水化合物、蛋白质和脂肪代谢紊乱。该疾病可引发大血管病变和微血管病变,进而导致多种严重并发症,如糖尿病神经病变、糖尿病肾病、糖尿病视网膜病变等。心血管并发症是其重要并发症之一,是导致糖尿病患者预后不良、致残率和死亡率升高的关键因素,临床表现涵盖冠心病、糖尿病性心肌病及心血管自主神经病变等多种病理情况。目前临床治疗方案包括血糖调控、血压管理、血脂调节、生活方式干预以及药物治疗等,传统药物递送系统存在显著局限性,具体表现为个体间药效学差异显著、药代动力学参数不理想、长期用药安全性问题突出、靶标特异性不足以及给药途径受限等。随着纳米技术与分子生物学研究的深入,基于高效靶向药物递送系统的治疗策略在糖尿病心血管并发症领域展现出广阔的应用前景,其中高效靶向药物递送系统的研发已成为该领域的重点研究方向。本综述系统梳理了糖尿病心血管并发症靶向治疗的最新研究进展,重点探讨了纳米载体技术、特异性靶向分子设计、智能响应型递送系统以及基因治疗等前沿领域的研究成果,旨在阐明分子靶向递送系统的临床转化价值,并为新型治疗策略的开发提供理论依据和研究思路。
Diabetes mellitus (DM) is a metabolic disorder characterized primarily by chronic hyperglycemia, with pathological features including disorders of carbohydrate, protein, and fat metabolism. This disease can lead to macrovascular and microvascular complications, resulting in various severe complications, such as diabetic neuropathy, diabetic nephropathy, and diabetic retinopathy. Cardiovascular complications are one of the major complications, serving as a key factor contributing to poor prognosis, increased disability rates, and mortality in diabetic patients. Clinical manifestations include coronary heart disease, diabetic cardiomyopathy, and cardiovascular autonomic neuropathy, among other pathological forms. Current clinical treatment options include blood glucose control, blood pressure management, lipid regulation, lifestyle interventions, and drug therapy. Traditional drug delivery systems have significant limitations, including marked interindividual differences in pharmacodynamics, suboptimal pharmacokinetic parameters, prominent long-term safety issues, insufficient target specificity, and limited administration routes. With the advancement of nanotechnology and molecular biology research, treatment strategies based on efficient targeted drug delivery systems have shown great potential in the field of diabetic cardiovascular complications. The development of efficient targeted drug delivery systems has become a key research direction in this field. This review systematically summarizes the latest research progress in targeted therapy for diabetic cardiovascular complications, focusing on the research achievements in cutting-edge fields such as nanocarrier technology, specific targeting molecule design, smart responsive delivery systems, and gene therapy. The aim is to elucidate the clinical translational value of molecular targeted delivery systems and provide theoretical basis and research insights for the development of novel therapeutic strategies.
| [1] |
国家心血管病中心, 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告 2024 概要[J].中国循环杂志, 2025, 40(6): 521-59. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
郑蕊, 屠叶清, 王慧, |
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
王斐, 陈要臻, 胡兴斌. 抗 CD-38 和抗 CD-47 单抗药物对输血相容性检测的干扰与应对策略研究进展[J].临床输血与检验, 2023, 25(4): 559-564. |
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
李思楠, 王玺, 安宇, |
| [28] |
|
| [29] |
Kim B, Kim YS, Li W, |
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
周高峰, 肖静, 周佳, |
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
李旻俊, 彭泽琳, 张良清. 外泌体药物递送载体构建及治疗心血管疾病的研究进展[J].中华实用诊断与治疗杂志, 2021, 35(7): 746-749. |
| [42] |
|
| [43] |
|
| [44] |
Okamura A, Yoshioka Y, Saito Y, |
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
李祥子, 胡平静, 朱振铎, |
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
易聪华, 徐青荷, 王淼, |
| [54] |
武小东. 多功能载药纳米胶束的结构设计与制备及其在动脉粥样硬化诊疗应用中的研究[D].长春:吉林大学, 2021. |
| [55] |
|
| [56] |
王娜, 杨丽霞. 细胞外基质金属蛋白酶诱导因子与心血管疾病[J].国际心血管病杂志, 2024, 51(6): 356-359. |
| [57] |
|
| [58] |
Kumar G, Saini M, |
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
熊凌, 郭昆全, 宋文英. AIM2 基因沉默对糖尿病大鼠心肌损伤的影响机制[J].贵州医科大学学报, 2021, 46(1): 44-50. |
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
Kankuri E. Positive feedback loop of miR-320 and CD36 regulates the hyperglycemic memory-induced diabetic diastolic cardiac dysfunction[J].Mol Ther Nucleic Acids, 2023, 32: 318-321. |
| [73] |
|
| [74] |
|
| [75] |
张笑涵, 刘乃需, 钦扬, |
| [76] |
|
| [77] |
|
国家自然科学基金青年项目(82204042)
国家自然科学基金面上项目(82373622)
山西省科技创新人才团队(青年)项目(202304051001038)
山西省科技合作交流专项项目(区域合作项目)(2022040411022)
国家卫生健康委员会尘肺病重点实验室开放课题(NHC202307)
山西省高等教育“百亿工程”科技引导专项(BYJL067)
/
| 〈 |
|
〉 |